Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Third Rock Ventures Quietly Launches Tango Therapeutics in Editas Medicine’s HQ

A new biotech company, Tango Therapeutics, is being launched by Third Rock Ventures and will be leasing 9,654 square feet of space at Editas Medicine headquarters in Cambridge, Mass.

Read More »

Why Pharma Giant AstraZeneca’s Market Value Gained $3.8 Billion In February 2017

AstraZeneca shareholders saw gains of 5.4 percent over the month of February, driven primarily by the London-based company’s oncology programs.

Read More »

Diabetes in pregnancy tied to altered fat cells in adult offspring

When pregnant mothers have diabetes, their children may have altered fat cells that make metabolic diseases in adulthood more likely, a small Danish study suggests.

Read More »

FDA Approves First Treatment for Nocturia

Serenity Pharmaceuticals announced that the U.S. FDA approved Noctiva (desmopressin acetate), the first FDA-approved therapy for nocturia.

Read More »

Precision Medicine: What Is It And Why Now?

Nearly two decades ago, the promise of precision medicine began making its mark on the pages of medical journals – along with speculation that “therapy with the right drug at the right dose in the right patient” – would define the future of medical treatment.

Read More »

Soy tied to longer life after breast cancer

Eating more soy may be tied to better survival odds for many women with breast cancer and may not be harmful for patients treated with hormones, a new study suggests.

Read More »

TG Therapeutics’ leukemia drug clears key study, shares soar

TG Therapeutics Inc. said a combination of its experimental cancer drug ublituximab and AbbVie Inc.’s Imbruvica outperformed Imbruvica alone in high-risk leukemia patients.

Read More »

Vertex to Acquire CTP-656 from Concert Pharmaceuticals for the Treatment of Cystic Fibrosis

Concert Pharmaceuticals Inc. announced that it has signed a definitive asset purchase agreement with Vertex Pharmaceuticals Inc. under which Vertex will acquire CTP-656.

Read More »

OncoCyte says study confirms accuracy of lung cancer blood test

OncoCyte Corp., which is developing diagnostics in the fledgling field of liquid biopsies, said a 300-patient validation study of its blood test for early detection of lung cancer has confirmed the accuracy reported from a prior trial.

Read More »


RELIGIOUS BELIEFS AND People PERCEPTIONS IN AMERICAN DERVISH Introduction Muneer characterization of white gals portrays as immoral men and women. The origins within the multiple figures mainly performs a brilliant purpose in molding their perceptions particularly mainly because not the Muslims are elevated up within the same exact way especially on issues of your faith […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom